Related Experiment Videos

The inverse relationship between cost and prognosis

The Laryngoscope
|March 1, 1984
PubMed

Insights

High-cost patients often have terminal illnesses, accounting for significant hospital charges and complications. Physician-clinicians have limited control over these substantial medical costs.

Area of Science:

  • Medical Economics
  • Healthcare Costs
  • Clinical Medicine

Background:

  • Physicians are often blamed for rising medical costs, but societal and political factors are significant contributors.
  • Clinicians recognize the high costs of serious illnesses, with recent literature addressing this issue in relation to medical care.
  • The limitations of medicine itself play a role in escalating healthcare expenses.

Purpose of the Study:

  • To analyze the relationship between high-cost patients, terminal illness, and resource utilization.
  • To investigate the incidence of complications and associated costs in high-cost patient populations.
  • To re-evaluate the extent of physician-clinician control over total medical costs.

Main Methods:

  • Analysis of a random sample of 776 adult high-cost patients.
  • Review of studies published in JAMA and The New England Journal of Medicine.
  • Examination of patient outcomes, including mortality and complication rates, two years post-discharge.

Main Results:

  • High-cost illness is strongly associated with terminal illness; 34% of high-cost patients died within two years.
  • These high-cost patients accounted for 39% of total hospital charges in the studied group.
  • The same patient group exhibited the highest incidence of surgical complications, incurring substantial costs.

Conclusions:

  • The majority of high-cost patients suffer from terminal conditions, representing a significant financial burden on the healthcare system.
  • While some complications may be avoidable, a high complication rate is likely inevitable in this patient group.
  • Physician-clinicians exert control over only a small fraction of the total costs associated with serious illnesses.

Related Concept Videos